Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Market Pulse: Federal Government Avoids Shutdown

By R&D Editors | October 3, 2016

The R&D Index: Market Watch for the week ending Sept. 30, 2016 closed at 1531.82 for the 25 companies in the R&D Index. The Index was down 0.38 percent (or 5.8 basis points) over the week ending Sept. 23, 2016. Eight companies gained value last week from 0.30 percent (Apple and Microsoft) to 9.16 percent (Qualcomm). Seventeen companies lost value from -0.42 percent (Sanofi) to -4.53 percent (Bristol-Myers Squibb).

The big R&D Index gainer for the week, Qualcomm (+9.2 percent), rose in value based on speculation that it will soon acquire NXP Semiconductors NV, an IC fabricator based in the Netherlands for a rumored $30 billion. The deal is expected to take up to three months to finalize and could fail, but NXP stock also rose 17 percent when the discussions were made public in the Wall Street Journal on Thursday indicating both companies’ stock holders approve of the possible acquisition. NXP, founded 60 years ago as Phillips Semiconductors, fabricates semiconductor devices for automotive systems, identification cards and transit cards. NXP acquired Austin, Texas-based Freescale Semiconductors in 2015. Freescale was formed in 2004 by the divestiture of the Semiconductor Products Sector of Motorola. Guido Dierick, NXP’s general counsel and its Netherlands chief, in interviews concerning the possible Qualcomm acquisition indicated that the overall semiconductor industry is heavily fragmented and he expects to see more consolidation over the next several years. Qualcomm is expected to invest $6.7 billion in R&D in 2017, a 6.6 percent increase over the $6.3 billion it invested in 2016. NXP is expected to invest $1.1 billion in R&D in 2017, a 9.3 percent increase over the $0.98 billion it invested in 2016.

Congress avoided a partial government shutdown at midnight on Oct. 1, by passing a short-term spending bill (referred to as a continuing resolution or CR) last Wednesday, which will support government operations through early December. Add-ons to the CR included full-year spending for the Veterans Administration, flood-assistance and funds for Zika virus research, Congressional leaders will also have to decide in November after the national elections, whether to pass another temporary budget extension which would go into the next administration, or to pass a full fiscal year budget (“omnibus”) as it has done in previous years. Omnibus spending bills generally kept spending at the level of the previous fiscal year without any increases. This type of budgeting has been detrimental to R&D spending and has hurt the overall country’s science and engineering research programs.

In other news, R&D Index member Pfizer announced last week that it has decided to not split the company into two divisions—one for new drugs and one for established drugs. Officials did not rule out pursuing this option in the future. The effort to split the company into two parts is estimated to already have cost Pfizer more than $600 million. 

    Ticker Exchange 2015 R&D billions$ 09/23/16 09/30/16 9/30/16 to 9/23/16 9/30/16 to 1/1/16
1 Microsoft MSFT NASDAQ 12,448 57.43 57.60 0.30% 3.82%
2 Intel INTC NASDAQ 12,128 37.19 37.75 1.51% 9.58%
3 Roche Holdings RHHBY OTC 10,242 31.54 30.97 -1.81% -10.15%
4 Toyota TM NYSE 9,112 117.66 116.06 -1.36% -5.67%
5 Johnson & Johnson JNJ NYSE 9,046 118.81 118.13 -0.57% 15.00%
6 Novartis NVS NYSE 8,935 81.48 78.96 -3.09% -8.27%
7 Apple AAPL NASDAQ 8,397 112.71 113.05 0.30% 7.40%
8 Pfizer PFE NYSE 7,690 34.26 33.87 -1.14% 4.57%
9 General Motors GM NYSE 7,500 32.12 31.77 -1.09% -6.59%
10 Merck & Co. MRK NYSE 6,704 62.96 62.41 -0.87% 18.16%
11 Ford Motor F NYSE 6,700 12.17 12.07 -0.82% -14.34%
12 Cisco CSCO NASDAQ 6,411 31.34 31.72 1.21% 16.71%
13 Oracle ORCL NYSE 6,042 39.23 39.28 0.13% 7.53%
14 Astra Zeneca PLC AZN NYSE 5,997 33.97 32.86 -3.27% -3.21%
15 Honda HMC NYSE 5,990 29.49 28.92 -1.93% -9.43%
16 Bristol-Myers Squibb BMY NYSE 5,920 56.48 53.92 -4.53% -21.63%
17 Qualcomm QCOM NASDAQ 5,833 62.75 68.50 9.16% 37.05%
18 Sanofi SA SNY NYSE 5,519 38.35 38.19 -0.42% -10.46%
19 Eli Lilly Co LLY NYSE 5,331 81.16 80.26 -1.11% -4.72%
20 GlaxoSmithKline GSK NYSE 5,250 43.42 43.13 -0.68% 6.89%
21 IBM IBM NYSE 5,247 154.98 158.85 2.50% 15.46%
22 Daimler DDAIY OTC 5,169 63.52 62.71 -1.28% -19.50%
23 Siemens SIE XETRA 4,929 106.20 104.20 -1.88% 15.93%
24 Bayer AG BAYN XETRA 4,649 91.48 89.43 -2.24% -23.04%
25 Ericsson ERIC NASDAQ 4,124 6.93 7.21 4.04% -24.97%
      Total 175,313 1537.63 1531.82 -0.38% 0.67%
                 
      Biopharmaceutical 673.91 662.13 -1.75% -4.68%
      Automotive 254.96 251.53 -1.35% -10.48%
      ICT   495.63 506.75 2.24% 13.51%

About the R&D Index/Market Pulse

R&D Magazine’s R&D Index is a weekly stock market summary of the top international companies involved in research and development. The top 25 industrial spenders of R&D in 2014 were selected based on the latest listings from Schonfeld & Associates’ June 2015 R&D Ratios & Budgets. These 25 companies include pharmaceutical (11 companies), automotive (5), ICT  (7) and conglomerate (2) organizations who invested a cumulative total of more than $170 billion in R&D in 2014, or approximately 10.8% of all the R&D spent in the world by government, industries and academia combined, according to R&D Magazine’s 2014 Global R&D Funding Forecast. The stock prices used in the R&D Index are tabulated from NASDAQ, NYSE, XETRA and OTC common stock prices (in U.S. dollars) for the companies selected at the close of stock trading business on the Friday preceding the publication of the R&D Index in R&D Magazine’s R&D Daily eNewsletter.

The companies used in the R&D Index include Microsoft, Intel, Roche Holdings, Novartis, Johnson & Johnson, Pfizer, Toyota Motor, General Motors, Merck & Co., Ford Motor, Cisco, Apple Computer, Sanofi SA, Qualcomm, IBM, Astra Zeneca plc, Honda Motor, Daimler, Oracle, GlaxoSmithKline, Siemens, Eli Lilly Co., Ericsson, Bristol-Myers Squibb and Bayer AG. Stock prices are based on those stocks traded on the U.S. exchanges. R&D Index trends (in the stock prices) are just one indicator of the amount of capital available to these high-technology companies to invest in R&D and should not be implied to indicate the absolute value of R&D investments made by these organizations. The companies chosen for the R&D Index have very large sophisticated internal and global R&D organizations with each company investing between $4.3 and $11.7 billion annually on their R&D efforts.

Related Articles Read More >

NSF caps indirect costs at 15% for new university grants
NSF chief quits as DOGE drives 55% budget cut and grant freeze
China could outspend the U.S. on R&D by 30%‑plus by 2030—even if the trade war roars on
White House clampdown puts $1 billion more at risk after $2.3 billion Harvard freeze
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE